Quality of Life in Adult Patients With SAPHO Syndrome and Chronic Nonbacterial Osteomyelitis, and Comparison to Chronic Rheumatic and Inflammatory Diseases

REFERENCES

1. 1.↵
   1. Lenert A,
   2. Ferguson PJ.

   Comparing children and adults with chronic nonbacterial osteomyelitis. Curr Opin Rheumatol 2020;32:421-6.

   OpenUrlPubMed
2. 2.↵
   1. Zhao DY,
   2. McCann L,
   3. Hahn G,
   4. Hedrich CM.

   Chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO). J Transl Autoimmun 2021;4:100095.

   OpenUrlPubMed
3. 3.↵
   1. Skrabl-Baumgartner A,
   2. Singer P,
   3. Greimel T,
   4. Gorkiewicz G,
   5. Hermann J.

   Chronic non-bacterial osteomyelitis: a comparative study between children and adults. Pediatr Rheumatol Online J 2019;17:49.

   OpenUrlPubMed
4. 4.↵
   1. Oliver M,
   2. Lee TC,
   3. Halpern-Felsher B, et al

   . Disease burden and social impact of pediatric chronic nonbacterial osteomyelitis from the patient and family perspective. Pediatr Rheumatol Online J 2018;16:78.

   OpenUrlPubMed
5. 5.↵
   1. Witt M,
   2. Meier J,
   3. Hammitzsch A,
   4. Proft F,
   5. Schulze-Koops H,
   6. Grunke M.

   Disease burden, disease manifestations and current treatment regimen of the SAPHO syndrome in Germany: results from a nationwide patient survey. Semin Arthritis Rheum 2014;43:745-50.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Winter E,
   2. Dekkers O,
   3. Andreasen C, et al

   . Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults. Ann Rheum Dis 2025;84:169-87.

   OpenUrlPubMed
7. 7.↵
   1. Huber AM,
   2. Lam PY,
   3. Duffy CM, et al

   . Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up. J Pediatr 2002;141:198-203.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. van der Kloot WA,
   2. Hamdy NAT,
   3. Hafkemeijer LCS, et al

   . The psychological burden of an initially unexplained illness: patients with sternocostoclavicular hyperostosis before and after delayed diagnosis. Health Qual Life Outcomes 2010;8:97.

   OpenUrlPubMed
9. 9.↵
   1. Ramautar AIE,
   2. Andela CD,
   3. Hamdy NAT,
   4. Winter EM,
   5. Appelman-Dijkstra NM.

   Determinants of quality of life in adult patients with chronic non-bacterial osteomyelitis (CNO) of the sternocostoclavicular region (SCCH): a Dutch single center study. J Clin Med 2022;11:1852.

   OpenUrlPubMed
10. 10.↵
    1. Oliver M,
    2. Jayatilleke A,
    3. Wu E, et al

    . Establishing core domain sets for chronic nonbacterial osteomyelitis (CNO) and synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO): a report from the OMERACT 2020 special interest group. Semin Arthritis Rheum 2021;51:957-61.

    OpenUrlPubMed
11. 11.↵
    1. Busija L,
    2. Ackerman IN,
    3. Haas R, et al

    . Adult measures of general health and health-related quality of life. Arthritis Care Res 2020;72 Suppl 10:522-64.

    OpenUrl
12. 12.↵
    1. EuroQol Research Foundation

    . EQ-5D-5L user guide. [Internet. Accessed August 1, 2025.]. Available from: https://euroqol.org/publications/user-guides
13. 13.↵
    1. Hvidberg MF,
    2. Petersen KD,
    3. Davidsen M, et al

    . Catalog of EQ-5D-3L health-related quality-of-life scores for 199 chronic conditions and health risks in Denmark. MDM Policy Pract 2023;8:23814683231159023.

    OpenUrlPubMed
14. 14.↵
    1. Van Wilder L,
    2. Rammant E,
    3. Clays E,
    4. Devleesschauwer B,
    5. Pauwels N,
    6. De Smedt D.

    A comprehensive catalogue of EQ-5D scores in chronic disease: results of a systematic review. Qual Life Res 2019;28:3153-61.

    OpenUrlPubMed
15. 15.↵
    1. Li C,
    2. Xu H,
    3. Gong L, et al

    . Work productivity and activity in patients with SAPHO syndrome: a cross-sectional observational study. Orphanet J Rare Dis 2022;17:381.

    OpenUrlPubMed
16. 16.↵
    1. Mulders-Manders CM,
    2. Kanters TA,
    3. van Daele PLA, et al

    . Decreased quality of life and societal impact of cryopyrin-associated periodic syndrome treated with canakinumab: a questionnaire based cohort study. Orphanet J Rare Dis 2018;13:59.

    OpenUrlPubMed
17. 17.↵
    1. Benhamou CL,
    2. Chamot AM,
    3. Kahn MF.

    Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? Clin Exp Rheumatol 1988;6:109-12.

    OpenUrlPubMed
18. 18.↵
    1. Rukavina I.

    SAPHO syndrome: a review. J Child Orthop 2015;9:19-27.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Herdman M,
    2. Gudex C,
    3. Lloyd A, et al

    . Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727-36.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Zhao Y,
    2. Ferguson PJ.

    Chronic nonbacterial osteomyelitis and chronic recurrent multifocal osteomyelitis in children. Pediatr Clin North Am 2018;65:783-800.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Barnes A,
    2. Bryant RV,
    3. Mukherjee S,
    4. Spizzo P,
    5. Mountifield R.

    Sleep quality is associated with reduced quality of life in inflammatory bowel disease through its interaction with pain. JGH Open 2024;8:e70021.

    OpenUrl
22. 22.↵
    1. Bató A,
    2. Brodszky V,
    3. Gergely LH, et al

    . The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa. Qual Life Res 2021;30:1477-90.

    OpenUrlPubMed
23. 23.
    1. Bloem AEM,
    2. Mostard RLM,
    3. Stoot N, et al

    . Patient activation for self-management in patients with idiopathic pulmonary fibrosis or sarcoidosis. Respiration 2022;101:76-83.

    OpenUrlPubMed
24. 24.
    1. Bloem AEM,
    2. Mostard RLM,
    3. Stoot N, et al

    . Severe fatigue is highly prevalent in patients with IPF or sarcoidosis. J Clin Med 2020;9:1178.

    OpenUrlPubMed
25. 25.
    1. Chamorro-de-Vega E,
    2. Calvo A,
    3. Fernández-Pacheco M, et al

    . Perceived quality of life by patients with immune-mediated inflammatory diseases treated with biological therapies. SACVINFA study. Farm Hosp 2024;48:265-71.

    OpenUrlPubMed
26. 26.
    1. Coyle C,
    2. Watson L,
    3. Whately-Smith C, et al

    . How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients. Rheumatology 2025;64:242-51.

    OpenUrlPubMed
27. 27.
    1. Glintborg B,
    2. Jensen DV,
    3. Engel S, et al

    . Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry. RMD Open 2021;7:e001505.

    OpenUrlAbstract/FREE Full Text
28. 28.
    1. Hagelund LM,
    2. Elkjær Stallknecht S,
    3. Jensen HH.

    Quality of life and patient preferences among Danish patients with ulcerative colitis—results from a survey study. Curr Med Res Opin 2020;36:771-9.

    OpenUrlPubMed
29. 29.
    1. Hashimoto A,
    2. Sonohata M,
    3. Mawatari M.

    The use of oral analgesics and pain self-efficacy are independent predictors of the quality of life of individuals with rheumatoid arthritis. Pain Res Manag 2020;2020:7409396.

    OpenUrlPubMed
30. 30.
    1. Kiltz U,
    2. Wiatr T,
    3. Redeker I,
    4. Baraliakos X,
    5. Fedorov K,
    6. Braun J.

    Effects of patient and disease characteristics on global functioning in patients with axial spondyloarthritis in routine care. Semin Arthritis Rheum 2022;55:152006.

    OpenUrlPubMed
31. 31.
    1. Kontodimopoulos N,
    2. Stamatopoulou E,
    3. Gazi S,
    4. Moschou D,
    5. Krikelis M,
    6. Talias MA.

    A comparison of EQ-5D-3L, EQ-5D-5L, and SF-6D utilities of patients with musculoskeletal disorders of different severity: a health-related quality of life approach. J Clin Med 2022;11:4097.

    OpenUrlPubMed
32. 32.
    1. Koumaki D,
    2. Rovithi E,
    3. Solia Apokidou E,
    4. Papadakis M,
    5. Katoulis A,
    6. Evangelou G.

    Cutaneous body image in patients with hidradenitis suppurativa: a hospital-based cross-sectional study. Sci Rep 2023;13:7898.

    OpenUrlPubMed
33. 33.
    1. Latteur J,
    2. Ernstsson O,
    3. Nilsson E,
    4. Jäghult S,
    5. Heintz E.

    Construct validity of EQ-5D-5L among patients with inflammatory bowel disease-a study based on real-world data from the Swedish Inflammatory Bowel Disease Registry. J Patient Rep Outcomes 2024;8:39.

    OpenUrlPubMed
34. 34.
    1. Lysen TS,
    2. Crombag EJGM,
    3. Lennaerts L, et al

    . Real world insights for psoriasis: the association of severity of skin lesions with work productivity, medical consumption costs and quality of life. J Dermatolog Treat 2024;35:2332615.

    OpenUrlPubMed
35. 35.
    1. Macfarlane GJ,
    2. Hollick RJ,
    3. Morton L, et al

    . The effect of COVID-19 public health restrictions on the health of people with musculoskeletal conditions and symptoms: the CONTAIN study. Rheumatology 2021;60:SI13-24.

    OpenUrlPubMed
36. 36.↵
    1. Murray PI,
    2. Sekaran A,
    3. Javidi H,
    4. Situnayake D.

    Interrelationships between health utility measurements, disease activity and psychological factors in Behçet’s disease. Gen Hosp Psychiatry 2021;70:103-8.

    OpenUrlPubMed
37. 37.↵
    1. Neilson AR,
    2. Jones GT,
    3. Macfarlane GJ,
    4. Pathan EM,
    5. McNamee P.

    Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data. Eur J Health Econ 2022;23:1357-69.

    OpenUrlPubMed
38. 38.
    1. Ramírez E,
    2. Romero-Jiménez R,
    3. Hernández-Muniesa B, et al

    . Evaluation of the hospital care quality perceived by patients with immune-mediated inflammatory diseases from the pharmacy service. SACVINFA study. J Clin Pharm Ther 2022;47:2020-9.

    OpenUrlPubMed
39. 39.
    1. Sakai R,
    2. Tanaka E,
    3. Inoue E, et al

    . Subjective symptoms contributing to the quality of life of rheumatoid arthritis patients with clinical remission from the IORRA database. Mod Rheumatol 2023;33:496-502.

    OpenUrlPubMed
40. 40.
    1. Thiele K,
    2. Albrecht K,
    3. Zink A, et al

    . Is the Rheumatoid Arthritis Impact of Disease (RAID) score a meaningful instrument for other inflammatory rheumatic diseases? A cross-sectional analysis of data from the German National Database. RMD Open 2022;8:e002342.

    OpenUrlAbstract/FREE Full Text
41. 41.
    1. Al-Jabi SW,
    2. Seleit DI,
    3. Badran A,
    4. Koni A,
    5. Zyoud SH.

    Impact of socio-demographic and clinical characteristics on functional disability and health-related quality of life in patients with rheumatoid arthritis: a cross-sectional study from Palestine. Health Qual Life Outcomes 2021;19:241.

    OpenUrlPubMed
42. 42.
    1. Feng J,
    2. Yu L,
    3. Fang Y,
    4. Zhang X,
    5. Li S,
    6. Dou L.

    Correlation between disease activity and patient-reported health-related quality of life in rheumatoid arthritis: a cross-sectional study. BMJ Open 2024;14:e082020.

    OpenUrlPubMed
43. 43.
    1. Haridoss M,
    2. Bagepally BS,
    3. Venkataraman K,
    4. Purushothaman SR.

    Health-related quality of life and its association with disease activity/functional status in rheumatoid arthritis: a cross-sectional study from South India. J Eval Clin Pract 2025;31:e14127.

    OpenUrlPubMed
44. 44.
    1. Wan C,
    2. Huang Y,
    3. Wang Q,
    4. Wang P,
    5. Xi X.

    Health utility of patients with established rheumatoid arthritis and its influencing factors: a multi-center study in China. Sci Rep 2024;14:14129.

    OpenUrlPubMed
45. 45.
    1. Arora K,
    2. Hazarika N,
    3. Kumari R,
    4. Chawla H.

    Quality of life in psoriasis: a cross-sectional study from North India. Indian J Dermatol 2024;69:38-43.

    OpenUrlPubMed
46. 46.
    1. Chiowchanwisawakit P,
    2. Orawongpaisarn A,
    3. Katchamart W.

    Construct validity, reliability, and threshold value for treatment goals of the Thai version of the 12-item Psoriatic Arthritis Impact of Disease Questionnaire for patients with psoriatic arthritis. Int J Rheum Dis 2024;27:e15139.

    OpenUrlPubMed
47. 47.
    1. Gao Z,
    2. Wang P,
    3. Hong J, et al

    . Health-related quality of life among Chinese patients with Crohn’s disease: a cross-sectional survey using the EQ-5D-5L. Health Qual Life Outcomes 2022;20:62.

    OpenUrlPubMed
48. 48.
    1. Mahfouz MS,
    2. Alqassim AY,
    3. Hakami FA, et al

    . Common skin diseases and their psychosocial impact among Jazan population, Saudi Arabia: a cross-sectional survey during 2023. Medicina 2023;59:1753.

    OpenUrl
49. 49.
    1. Roukas C,
    2. Miller L,
    3. Cléirigh Büttner F, et al

    . Impact of pain, fatigue and bowel incontinence on the quality of life of people living with inflammatory bowel disease: a UK cross-sectional survey. U Eur Gastroenterol J 2025;13:364-75.

    OpenUrl
50. 50.
    1. Su J,
    2. Liu T,
    3. Li S,
    4. Zhao Y,
    5. Kuang Y.

    A mapping study in mainland China: predicting EQ-5D-5L utility scores from the psoriasis disability index. J Med Econ 2020;23:737-43.

    OpenUrlPubMed
51. 51.
    1. Szabó Á,
    2. Brodszky V,
    3. Rencz F.

    Comparing EQ-5D-5L, PROPr, SF-6D and TTO utilities in patients with chronic skin diseases. Eur J Health Econ 2025;26:627-39.

    OpenUrlPubMed
52. 52.↵
    1. Yu L,
    2. Yang H,
    3. Lu L, et al

    . Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with ankylosing spondylitis. Health Qual Life Outcomes 2024;22:61.

    OpenUrlPubMed
53. 53.↵
    1. Jiang R,
    2. Janssen MFB,
    3. Pickard AS.

    US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples. Qual Life Res 2021;30:803-16.

    OpenUrlCrossRefPubMed
54. 54.↵
    1. Bernabé E,
    2. Marcenes W,
    3. Mather J,
    4. Phillips C,
    5. Fortune F.

    Impact of Behçet’s syndrome on health-related quality of life: influence of the type and number of symptoms. Rheumatology 2010;49:2165-71.

    OpenUrlCrossRefPubMed
55. 55.↵
    1. Boeker LS,
    2. Kuemmerle-Deschner JB,
    3. Saur SJ,
    4. Klotsche J,
    5. Erbis G,
    6. Hansmann S.

    Health-related quality of life, continuity of care and patient satisfaction: long-term outcomes of former patients of the Tübingen Transition Program (TTP)—a retrospective cohort study. Pediatr Rheumatol Online J 2022;20:121.

    OpenUrlPubMed